At insitro, we are combining human biology and machine learning to discover and develop new therapeutics. The heart of our strategy is to produce large data sets that will drive machine learning and yield key biological and therapeutic insights. This strategy requires a seamless, robust, and effective operation that spans multiple projects, some partnered and some in-house. Our success relies on working across functions, including high-throughput biology, automation, functional genomics, data science, machine learning, translational science, and drug discovery, to ensure that projects have what they need for successful execution. Our cross functional work also requires critical support from our G&A teams, with the Legal team responsible for providing counseling and hands on support for transaction structuring, business negotiations, risk mitigation, compliance, and intangible asset management.
We are seeking an experienced Corporate Attorney to assist with these responsibilities and support the growth and operational excellence of insitro. Reporting to the General Counsel, you will have a broad scope of responsibilities tied to structuring insitro’s arrangements with external parties and developing its legal operations internally to support a growing, diverse employee base. You will counsel internal clients across science, engineering and G&A groups on contract negotiations, business planning and legal risk mitigation. You will understand the business needs and perspectives of project teams conducting work across diverse fields of business, science and technology, including development and advancement of therapeutic pipelines, stem cell engineering, chemical engineering, software, machine learning, and automation—translating that understanding into pragmatic legal advice and solutions. You will anticipate, investigate and proactively address legal and regulatory issues presented by a complex, multi-faceted business geared toward drug development. Your primary duties will involve supporting company financings, advising on investor matters, establishing/managing compliance programs, and negotiating agreements with external parties, including NDAs, MTAs, collaboration agreements, vendor agreements and commercial real estate arrangements. You will also assume substantial responsibility for supporting corporate development, including strategic partnership arrangements, alliance management, M&A events and international transactions. In partnership with other professionals in the Legal Department and throughout the company you will help develop information management and communication systems, legal content and engagement strategies to support all aspects of insitro’s internal operations and support for its workforce.
This role will regularly interact with Finance, HR, Business Development, Program Management, IT and various members of our scientific and engineering Teams.
You will be joining an exciting biotech startup that has long-term stability due to significant funding, yet is very much in its formative growth stage. A lot can change in this early and exciting phase, providing many opportunities for significant impact across several functions and disciplines. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us in leading the way to better medicines through predictive models by integrating machine learning and biology at scale.
Nice to Haves
Benefits at insitro
insitro is a data-driven drug discovery and development company using machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company is applying state-of-the-art technologies from bioengineering to create massive data sets that enable the power of modern machine learning methods to be brought to bear on key bottlenecks in pharmaceutical R&D. The resulting predictive models are used to accelerate target selection, to design and develop effective therapeutics, and to inform clinical strategy. insitro was launched in 2018 with a Series A of $100M funded by top investors including a16z, Arch Venture Partners, Foresite Capital, GV, and Third Rock Ventures. In 2019 the company announced a collaboration with Gilead Sciences in the area of NASH, a collaboration with BMS in the area of ALS, and in mid 2020, announced a Series B financing of $143M including current investors and new investors Canada Pension Plan Investment Board (CPP Investments), T. Rowe Price, BlackRock, Casdin Capital and other leading investors. The company is located in South San Francisco, CA. For more information about insitro, please visit the company’s website at www.insitro.com
Your application was submitted successfully.